Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...
SK bioscience is accelerating late-stage development of its innovative pneumococcal vaccine candidate targeting the glob...
South Korea-based SK bioscience has signed an agreement with Colombia's state-owned pharmaceutical company VECOL for vac...
The International Vaccine Institute (IVI) and Hilleman Laboratories have entered into a strategic part...
Japan-based Meiji Seika Pharma Co. has announced that KM Biologics Co., a group company of Meiji Seika Pharma, has enter...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Pasteur Network (PN), in Paris, have signed ...
Transgene, a French biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, a...
South Korea-based SK bioscience has signed a contract with Germany's IDT Biologika for the contract development and manu...
SK pharmteco is embarking into strategic initiatives within its viral vector business, while reaffirming its long-term g...
Taiwan-based Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics, based in Paris, have achieved a milestone ...
Australia-based CSL Seqirus has entered into a pioneering long-term agreement with Pan American Health Organization...
SK pharmteco announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France....
Pfizer Japan Inc., and ASKA Pharmaceutical have announced that they will begin co-promotion of the Respiratory Syncytial...
New research co-led by Burnet Institute and Walter and Eliza Hall Institute of Medical Research (WEHI) in Australia...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash Universit...
South Korea-based SK bioscience has announced that together with IDT Biologika (IDT) and Australian biotechnology compan...
Zimbabwe has taken a groundbreaking step in its fight against HIV by launching the administration of lenacapavir, a long...
The European Union is committing €225 million to speed up the development of next-generation flu vaccines that will...
The World Health Organization (WHO) has prequalified an additional novel oral polio vaccine type 2 (nOPV2), further...
A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-res...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics, a South Korea-based contract ...
South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine under a...
SK bioscience has announced the new domestic launch of MenQuadfi Injection (MenQuadfi, MenACWY-TT), a quadrivalent menin...
Researchers from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIS...
